{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:58:25Z","timestamp":1792511905920,"version":"4.5.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2022NSFSC1432, 2022NSFSC1591"],"award-info":[{"award-number":["2022NSFSC1432, 2022NSFSC1591"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","award":["2020YFS0219, 2021YFS0173"],"award-info":[{"award-number":["2020YFS0219, 2021YFS0173"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["21HXFH041"],"award-info":[{"award-number":["21HXFH041"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>The coexistence of neuromyelitis optica spectrum disorder (NMOSD) with other autoimmune diseases has been well recognized. However, the causal association between these two conditions has not been fully studied. The etiology and therapies of NMOSD coexisting with autoimmune diseases also need to be elucidated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed two-sample Mendelian randomization (MR) analysis to examine the causality. Genome-wide association (GWAS) summary data from NMOSD, autoimmune thyroid disease (AITD), systemic lupus erythematosus (SLE), and Sjogren\u2019s syndrome (SS) were used to identify genetic instruments. Causal single-nucleotide polymorphisms (SNPs) were annotated and searched for cis-expression quantitative trait loci (cis-eQTL) data. Pathway enrichment analysis was performed to identify the mechanism of NMOSD coexisting with AITD, SLE, and SS. Potential therapeutic chemicals were searched using the Comparative Toxicogenomics Database.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The MR analysis found that AITD, SLE, and SS were causally associated with NMOSD susceptibility, but not vice versa. Gene Ontology (GO) enrichment analysis revealed that MHC class I-related biological processes and the interferon-gamma-mediated signaling pathway may be involved in the pathogenesis of NMOSD coexisting with AITD, SLE, and SS. A total of 30 chemicals were found which could inhibit the biological function of cis-eQTL genes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our findings could help better understand the etiology of NMOSD and provide potential therapeutic targets for patients with coexisting conditions.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.959469","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T12:17:22Z","timestamp":1664540242000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["The causal relationship between neuromyelitis optica spectrum disorder and other autoimmune diseases"],"prefix":"10.3389","volume":"13","author":[{"given":"Xiaofei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlin","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyao","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiancheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41572-020-0214-9","article-title":"Neuromyelitis optica","volume":"6","author":"Jarius","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2018.11.008","article-title":"Autoimmune diseases associated with neuromyelitis optica spectrum disorders: A literature review","volume":"27","author":"Shahmohammadi","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102425","article-title":"Epidemiology and comorbidities of adult multiple sclerosis and neuromyelitis optica in Taiwan, 2001-2015","volume":"45","author":"Fang","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"B4","unstructured":""},{"key":"B5","unstructured":""},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408","article-title":"The MR-base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007081","article-title":"Orienting the causal relationship between imprecisely measured traits using GWAS summary data","volume":"13","author":"Hemani","year":"2017","journal-title":"PloS Genet"},{"key":"B8","unstructured":""},{"key":"B9","unstructured":""},{"key":"B10","year":""},{"key":"B11","unstructured":""},{"key":"B12","unstructured":""},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.102899","article-title":"A case of longitudinally extensive transverse myelitis in an 80-year-old patient with systemic lupus erythematous and anti-aquaporin 4 antibodies","volume":"51","author":"Pirro","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.5606\/ArchRheumatol.2017.6201","article-title":"A case of primary sj\u00f6gren\u2019s syndrome presenting as mass-like encephalitis, with progression to neuromyelitis optica spectrum disorder","volume":"32","author":"Lee","year":"2017","journal-title":"Arch Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jneuroim.2015.10.007","article-title":"Anti-aquaporin-4 autoantibodies in systemic lupus erythematosus persist for years and induce astrocytic cytotoxicity but not CNS disease","volume":"289","author":"Alexopoulos","year":"2015","journal-title":"J Neuroimmunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1177\/1352458515613165","article-title":"Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study","volume":"22","author":"Kovacs","year":"2016","journal-title":"Mult Scler"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4137\/CCRep.S15177","article-title":"Systemic lupus erythematosus (SLE) complicated by neuromyelitis optica (NMO - devic\u2019s disease): Clinic-pathological report and review of the literature","volume":"7","author":"Adawi","year":"2014","journal-title":"Clin Med Insights Case Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1191\/0961203306lu2265cr","article-title":"Neuromyelitis optica (Devic\u2019s syndrome) as first manifestation of systemic lupus erythematosus","volume":"15","author":"Jacobi","year":"2006","journal-title":"Lupus"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000023029","article-title":"Recurrent optic neuritis in a patient with sjogren syndrome and neuromyelitis optica spectrum disorder: A case report","volume":"99","author":"Zheng","year":"2020","journal-title":"Medicine"},{"key":"B21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12883-018-1170-9","article-title":"Syringomyelia-like syndrome in neuromyelitis optica spectrum disorder complicated with sjogren\u2019s syndrome: A case report","volume":"18","author":"Li","year":"2018","journal-title":"BMC Neurol"},{"key":"B22","doi-asserted-by":"crossref","DOI":"10.1201\/9781315533247","volume-title":"Janeway\u2019s immunobiology 9th edition","author":"Murphy","year":"2016"},{"key":"B23","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3390\/brainsci12030372","article-title":"Relationship between the clinical characteristics in patients with neuromyelitis optica spectrum disorders and clinical immune indicators: A retrospective study","volume":"12","author":"Cai","year":"2022","journal-title":"Brain Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/acn3.51241","article-title":"CD8+ T cell subpopulations and pro-inflammatory cytokines in neuromyelitis optica spectrum disorder","volume":"8","author":"Shi","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abo7799","article-title":"Epstein-Barr Virus as a driver of multiple sclerosis","volume":"7","author":"Sollid","year":"2022","journal-title":"Sci Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded b cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-308095","article-title":"Epstein-Barr Virus persistence and reactivation in neuromyelitis optica","volume":"86","author":"Masuda","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.15761\/CCRR.1000411","article-title":"Epstein - Barr virus infection in a patient with neuromyelitis optica spectrum disorder and sj\u00f6gren\u2019s syndrome: A case report and review of literature","volume":"4","author":"Levinson","year":"2018","journal-title":"Clin Case Rep Rev"},{"key":"B29","doi-asserted-by":"publisher","first-page":"688","DOI":"10.3390\/jcm10040688","article-title":"Association between optic neuritis and inflammatory bowel disease: A population-based study","volume":"10","author":"Hsieh","year":"2021","journal-title":"J Clin Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2011.1","article-title":"Monoclonal antibody therapy-associated neurological disorders","volume":"7","author":"Bosch","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15318","article-title":"Demyelinating events following anti-tumor necrosis factor alpha therapy: Rare but challenging to treat","volume":"29","author":"Kal\u00e9n","year":"2022","journal-title":"Eur J Neurol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519828601","article-title":"Iatrogenic CNS demyelination in the era of modern biologics","volume":"25","author":"Kumar","year":"2019","journal-title":"Mult  Scler  J"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1177\/0961203318760994","article-title":"Refractory neuromyelitis optica spectrum disorder in systemic lupus erythematosus successfully treated with rituximab","volume":"27","author":"Shidahara","year":"2018","journal-title":"Lupus"},{"key":"B34","doi-asserted-by":"publisher","first-page":"76","DOI":"10.26442\/terarkh201890576-80","article-title":"The efficacy of rituximab in the therapy of neuromyelitis optica in a patient with sjogren\u2019s syndrome: Case-report and literature review","volume":"90","author":"Torgashina","year":"2018","journal-title":"Ter Arkh"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2010.09.021","article-title":"Devic\u2019s syndrome and SLE: challenges in diagnosis and therapeutic possibilities based on two overlapping cases","volume":"10","author":"Polg\u00e1r","year":"2011","journal-title":"Autoimmun Rev"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2013.861333","article-title":"Neuromyelitis optica spectrum disorder complicated with sjogren syndrome successfully treated with tocilizumab: A case report","volume":"26","author":"Komai","year":"2016","journal-title":"Mod Rheumatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517717090","article-title":"Dimethyl fumarate for patients with neuromyelitis optica spectrum disorder","volume":"24","author":"Pitarokoili","year":"2018","journal-title":"Mult  Scler  J"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000729","article-title":"Dimethyl fumarate suppresses granulocyte macrophage colony-stimulating factor-producing Th1 cells in CNS neuroinflammation","volume":"7","author":"Safavi","year":"2020","journal-title":"Neurology(R) neuroimmunol Neuroinflamm"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601532","article-title":"Dimethyl fumarate selectively reduces memory T cells and shifts the balance between Th1\/Th17 and Th2 in multiple sclerosis patients","volume":"198","author":"Wu","year":"2017","journal-title":"J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.959469\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T12:17:28Z","timestamp":1664540248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.959469\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":39,"alternative-id":["10.3389\/fimmu.2022.959469"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.959469","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,29]]},"article-number":"959469"}}